GLP受容体作動薬とGIP/GLP-1受容体作動薬が報酬系に及ぼす影響の解明

• Project/Area Number: 25K22632
• Research Category: Grant-in-Aid for Challenging Research (Exploratory)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 54:Internal medicine of the bio-information integration and related fields
• Research Institution: Nagoya University
• Principal Investigator: 有馬 寛 名古屋大学, 医学系研究科, 教授 (50422770)
• Project Period (FY): 2025-06-27 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000); Fiscal Year 2026: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000); Fiscal Year 2025: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)